The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2023

Filed:

Mar. 23, 2018
Applicant:

Dnarx, San Francisco, CA (US);

Inventors:

Robert James Debs, San Francisco, CA (US);

Timothy D. Heath, Madison, WI (US);

Chakkrapong Handumrongkul, Richmond, VA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/88 (2006.01); C12N 15/85 (2006.01); A61K 31/7105 (2006.01); A61K 39/395 (2006.01); A61K 9/127 (2006.01); C12N 15/10 (2006.01); C07K 16/10 (2006.01); C07K 16/40 (2006.01); A61K 9/00 (2006.01); C12N 15/87 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 48/005 (2013.01); A61K 9/0019 (2013.01); A61K 9/127 (2013.01); A61K 9/1272 (2013.01); A61K 31/7105 (2013.01); A61K 39/39558 (2013.01); C07K 16/1018 (2013.01); C07K 16/40 (2013.01); C12N 15/102 (2013.01); C12N 15/85 (2013.01); C12N 15/87 (2013.01); C12N 15/88 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); A61K 2039/53 (2013.01); A61K 2039/55561 (2013.01); C07K 2317/10 (2013.01); C07K 2317/76 (2013.01); C12N 2310/20 (2017.05);
Abstract

The present invention provides compositions, systems, kits, and methods for expression of one or more biomolecules in a subject, human or non-human mammal, (e.g., at therapeutic levels for the extended periods of time required to produce therapeutic effects). In certain embodiments, compositions, systems, kits, and methods are provided that comprise a first composition comprising polycationic structures (e.g., empty cationic liposomes, cationic micelles, cationic emulsions, or cationic polymers) and a second composition comprising expression vectors (e.g., non-viral expression vectors not associated with liposomes or other carriers) encoding one or more biomolecules of interest.


Find Patent Forward Citations

Loading…